首页> 中国专利> 一种针对新型冠状病毒传播机理动力学进行循迹靶向灭活抑制感染的纯中药配方

一种针对新型冠状病毒传播机理动力学进行循迹靶向灭活抑制感染的纯中药配方

页面导航

摘要
著录项
法律信息
相似文献

摘要

本发明是一种针对新型冠状病毒传播机理动力学进行循迹靶向灭活抑制感染的纯中药配方，是根据新型冠状病毒的传播方式及传染途径和发展现状制成的一种覆盖病毒传播路径进行循迹靶向灭活抑制感染的纯中药配方。适用于日常工作和生活环境无死角病毒灭活，尤其适用于医疗机构、工作场所、公共场所等人群密集场所。本发明涉及的消毒产品制作工序简单易行，效果显著，可作为日常工作生活中必备自制空气杀菌消毒香薰使用。

著录项

公开/公告号CN111713515A

专利类型发明专利
公开/公告日2020-09-29

原文格式PDF
申请/专利权人宁夏清华园知识产权研究与开发有限公司;
展开▼

申请/专利号CN202010248971.3
发明设计人张文举;张嘉馨;张嘉乐;王皓;
展开▼

申请日2020-04-01
分类号A01N65/36(20090101);A01N65/22(20090101);A01N65/12(20090101);A01N65/08(20090101);A01N25/18(20060101);A01N25/20(20060101);A01P1/00(20060101);A61K36/282(20060101);A61K36/284(20060101);A61K36/346(20060101);A61K36/532(20060101);A61K36/535(20060101);A61K36/752(20060101);A61L9/02(20060101);A61P11/00(20060101);A61P31/14(20060101);
代理机构
代理人
地址 750021 宁夏回族自治区银川市西夏区广顺路80号办公楼
入库时间 2023-06-19 08:25:29

法律信息

法律状态公告日

法律状态信息

法律状态
2022-01-04

发明专利申请公布后的视为撤回 IPC(主分类):A01N65/36 专利申请号:2020102489713 申请公布日:20200929

发明专利申请公布后的视为撤回

相似文献

专利
中文文献
外文文献

1. 一种针对新型冠状病毒传播机理动力学进行循迹靶向灭活抑制感染的纯中药配方 [P] . 中国专利： CN111713515A . 2020-09-29
2. 针对新型冠状病毒感染从诊断到确诊的试剂盘 [P] . 中国专利： CN212321638U . 2021-01-08
3. PEPTIDE, PEGUILLED PEPTIDE, COMPOSITION, PHARMACEUTICAL COMPOSITION, BOTTLE, DISINFECTION SOLUTION, METHOD FOR GROWTH INHIBITION, REPLICATION OR INFECTIVITY OF A MICRO-ORGANISM, METHOD FOR INHIBITION OF A BACTERIAL GROWTH, BACTERIAL GROWTH INHIBITION, TREATMENT OF A MICRO-ORGANISM INFECTION IN A SUBJECT AND PREVENTION OF A DISEASE IN A SUBJECT CAUSED BY OR ASSOCIATED WITH A MICRO-ORGANISM INFECTION, METHOD FOR INHIBITING BACTERIAL GROWTH IN A SUBJECT, A METHOD OF TREATMENT OF A BACTERIAL TREATMENT SUBJECT AND TREATMENT OF A DISEASE CAUSED BY OR ASSOCIATED WITH A BACTERIAL INFECTION, METHOD FOR PREVENTING A DISEASE CAUSED BY OR ASSOCIATED WITH A BACTERIAL INFECTION IN A SUBJECT, METHOD FOR INHIBITION OF VIRAL REPLICATION IN A SUBJECT TO A SUBJECT TO A SUBJECT ON A SUBJECT AND TREATMENT OF A DISEASE CAUSED BY OR ASSOCIATED WITH A VIRAL INFECTION IN A SUBJECT, METHOD FOR THE PREVENTION OF A DISEASE CAUSED BY OR ASSOCIATED WITH A VIRAL INFECTION IN A SUBJECT, METHOD FOR DISINFECTING AN INA [P] . BR112017028190A2 . 2018-09-04

机译：肽，规定的肽，成分，药物成分，瓶，消毒溶液，微生物的生长抑制，复制或感染的方法，细菌生长的抑制方法，细菌生长的抑制作用，治疗由微生物感染引起或与之有关的疾病的预防，疾病的抑制方法，一种细菌治疗方法的治疗和一种或多种细菌引起的疾病的治疗感染，预防由细菌感染引起的疾病或与之相关的疾病的方法，在受试者体内抑制病毒复制的方法以及对由细菌引起或与之相关的疾病的治疗在主题中，一种预防由对象中的病毒感染引起或与之相关的疾病的方法，一种用于对INA进行消毒的方法
4. Isolated molecular structure, enveloping and combining viruses, vaccine formulation, anti-corporomonoclonal, polyclonal antiserum, jelly, foam, contraceptive cream or ointment, mammal and human blood samples, kit, cell line, treatment processes or prevention of infection by a virus in subject, treatment or prevention of infection by a human infection, inhibition of infection by a virus in a blood sample, inhibition of infection by HIV in a human blood sample, decontamination of surgical or dental tools, monitoring of antibody product to molecular structure, production of an immunogen for use in a vaccine for treatment or prevention of infection by a virus, and production of an immunogen for use in a vaccine for the treatment or prevention of HIV infection, cross-linked structure, monoclonal antibody to the structure , decontamination of surgical or dental tools, pro selection process of a molecular structure for vaccine efficacy, mammal, isolated protein complex, devacin formulation, p [P] . BR9912732A . 2001-11-27

机译：分离的分子结构，包膜和合并病毒，疫苗制剂，抗体单克隆抗体，多克隆抗血清，果冻，泡沫，避孕霜或软膏，哺乳动物和人类血液样本，试剂盒，细胞系，治疗过程或预防对象被病毒感染，治疗或预防人类感染的感染，抑制血液样本中的病毒感染，抑制人类血液样本中的HIV感染，对外科工具或牙科工具进行去污，监控抗体产物的分子结构，用于疫苗中的用于治疗或预防病毒感染的免疫原，以及用于疫苗中的用于治疗或预防HIV感染的免疫原的生产，交联结构，针对该结构的单克隆抗体，外科手术的净化或牙科工具，用于疫苗效力的分子结构的专业选择过程，哺乳动物，分离的蛋白复合物，解体素制剂，p
5. pencicillin-binding protein, nucleic acid, antibody or antibody fragment, medicament, pharmaceutical composition, uses of at least one penicillin-binding protein or fragment or variant or fragment thereof, of at least one nucleic acid and of at least one antibody or antibody fragment, in vitro antibody detection methods directed against neisseria meningitidis infection from a penicillin-binding protein, nucleic acid, antibody or an antibody fragment, pharmaceutical composition of at least one penicillin-binding protein or fragment or variant or variant thereof, of at least one nucleic acid and at least one antibody directed against neisseria meningitidis infection from a biological sample of a mammal and in vitro diagnosis of neisseria miningitidis infection from a biological sample from a mammal and monoclonal antibody [P] . BRPI0610802A2 . 2016-11-16

机译：青霉素结合蛋白，核酸，抗体或抗体片段，药物，药物组合物，至少一种青霉素结合蛋白或其片段或变异体或片段，至少一种核酸和至少一种抗体或抗体片段的用途，针对脑膜炎奈瑟菌的青霉素结合蛋白，核酸，抗体或抗体片段感染的体外抗体检测方法，至少一种青霉素结合蛋白或其片段或变异体或变异体，至少一种核酸的药物组合物酸和至少一种针对哺乳动物生物样品中脑膜炎奈瑟氏菌感染的抗体以及来自哺乳动物生物样品中的矿业性奈瑟氏球菌感染的体外诊断和单克隆抗体